ArticleJournal of neuromuscular diseases2023

Patients with Spinal Muscular Atrophy Type 1 Achieve and Maintain Bulbar Function Following Onasemnogene Abeparvovec Treatment.

Katlyn E McGrattan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.